Carl P. Decicco's Insider Trades & SAST Disclosures
Carl P. Decicco's most recent trade in Foghorn Therapeutics Inc was a trade of 104,310 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on Dec. 9, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carl P. Decicco.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share. | 09 Dec 2021 | 104,310 | 362,707 | - | 3.7 | 388,033 | Common Stock |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 76,892 | 186,571 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 27,418 | 34,273 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Foghorn Therapeutics Inc | Carl P. Decicco | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 27 Oct 2020 | 5,500 | 258,397 | - | 16 | 88,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges